Ionis Pharmaceuticals | Des Atouts



Assets Changement Date
Adcock Ingram Holdings ZAR 8.74B 388.13M 2024-12
Agios Pharmaceuticals USD 1.47B 84.28M 2025-06
Alnylam Pharmaceuticals USD 4.57B 352.21M 2025-06
Arrowhead Research USD 1.38B 192.89M 2025-06
Astellas Pharma JPY 3.34T 3.71B 2025-06
BioMarin Pharmaceutical USD 7.46B 309.33M 2025-06
Celltrion KRW 20.96T 96.41B 2025-03
Cspc Pharmaceutical CNY 44.39B 3.51B 2024-12
Divis Laboratories Ltd 169.32B 13.46B 2025-03
Exelixis USD 2.68B 159.17M 2025-07
Halozyme Therapeutics USD 2.05B 142.63M 2025-06
Ionis Pharmaceuticals USD 2.99B 172.18M 2025-06
Kangmei Pharma CNY 13.71B 83.85M 2025-03
Knight Therapeutics CAD 962.29M 16.93M 2024-09
Laboratorios Farma EUR 832.02M 25.3M 2024-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 65.33M 6.17M 2024-12
Moderna USD 12.01B 694M 2025-06
Neuren Pharmaceuticals AUD 409.71M 181.55M 2024-12
Neurocrine Biosciences USD 3.89B 202.1M 2025-06
Novartis USD 104.4B 4.45B 2025-06
OPKO Health USD 2.2B 55.9M 2024-12
Organigram Holdings CAD 479.21M 71.35M 2024-12
Pfizer USD 206.1B 1.93B 2025-06
Pharma Mar EUR 348.25M 14.75M 2025-06
PTC Therapeutics USD 2.63B 21.23M 2025-06
Qiagen NV USD 5.82B 278.39M 2025-06
Regeneron Pharmaceuticals USD 38.22B 674M 2025-06
Roche Holding CHF 101.8B 6.02B 2024-12
Sarepta Therapeutics USD 3.68B 214.43M 2025-06
Sartorius EUR 10.03B 85.1M 2025-06
Sino Biopharmaceutical CNY 65.41B 1.3B 2024-12
Tilray USD 4.19B 70.11M 2024-11
Ultragenyx Pharmaceutical USD 1.31B 5.66M 2025-06
Vertex Pharmaceuticals USD 24.04B 1.16B 2025-06
Zz Pientze Pharmaceu 18.48B 944.93M 2025-03


Ionis Pharmaceuticals Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.